Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________________________
FORM 6-K
__________________________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month ended September 30, 2026
Commission File Number 001-38332
__________________________________
QIAGEN N.V.
(Translation of registrant’s name into English)
__________________________________
Hulsterweg 82
5912 PL Venlo
The Netherlands
(Address of principal executive office)
__________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ý Form 40-F o
QIAGEN N.V.
Form 6-K
Table of Contents
| | | | | | | | |
| Item | | Page |
Other Information | | |
Signatures | | |
Exhibit Index | | |
Other Information
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) issued a press release on August 24, 2026 with details of the appointment of Jonathan M. Pratt as Chief Executive Officer effective September 1, 2026. Also, effective September 1, 2026, Thierry Bernard stepped down as member of the QIAGEN N.V. Managing Board. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | |
| | |
| QIAGEN N.V. | |
| |
| By: | /s/ Roland Sackers |
| | Roland Sackers |
| | Chief Financial Officer |
Date: September 8, 2026
Exhibit Index
| | | | | | | | |
Exhibit
No. | | Exhibit |
| | |
| | Press Release dated August 24, 2026 |